Lawsuits claim Tylenol use in pregnancy causes autism

2 Mwezi wa kumi, 2025 Imeripotiwa na AI

More than 100 lawsuits have been filed against acetaminophen manufacturers, including Johnson & Johnson, alleging that the drug's use during pregnancy increases the risk of autism and ADHD in children. These legal actions stem from scientific studies showing associations between prenatal exposure and neurodevelopmental disorders. The cases highlight growing concerns over the safety of a widely used pain reliever.

FDA Approves Injectable Form of Merck's Keytruda

The U.S. Food and Drug Administration has granted approval for an injectable version of Merck's blockbuster cancer drug Keytruda, marking a significant advancement in treatment options for patients with certain types of cancer. This subcutaneous formulation promises greater convenience over the traditional intravenous method, potentially improving patient adherence and reducing healthcare burdens. The decision, announced on September 19, 2025, underscores ongoing innovations in oncology amid rising demands for more accessible therapies.

Pfizer stock rises after aligning with Trump on drug pricing

1 Mwezi wa kumi, 2025 Imeripotiwa na AI

Pfizer's shares climbed on Monday after the company expressed support for former President Donald Trump's proposal to allow imports of lower-priced drugs from Canada. This stance marks a shift for the pharmaceutical giant, which has historically opposed such measures. The move comes amid ongoing debates over U.S. drug costs.

Trump unveils drug pricing deal with AstraZeneca

President Donald Trump announced a deal with AstraZeneca on Friday, offering discounts on medicines for Medicaid in exchange for tariff relief. This follows a similar agreement with Pfizer last week as part of efforts to lower U.S. prescription drug prices. The White House aims to use these pacts as a model for negotiations with other drugmakers.